Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-029446
Filing Date
2024-03-11
Accepted
2024-03-11 17:26:33
Documents
1
Period of Report
2024-03-08

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 32555
  Complete submission text file 0000950170-24-029446.txt   34042
Mailing Address C/O CREDIT SUISSE 1ST BOSTON PRV EQY 11 MADISON AVENUE NEW YORK NY 10010
Business Address
HUNT RONALD (Reporting) CIK: 0001247851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38800 | Film No.: 24739224

Mailing Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 (650) 443-7400
Harpoon Therapeutics, Inc. (Issuer) CIK: 0001708493 (see all company filings)

EIN.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)